CD8A and neoplasm: Evaluation of MSI status and CD8+ TILs in addition to PD-L1 expression on tumor cells is considered important from the perspective of assessing the condition of the tumor microenvironment based on the immunity cycle, which is expected to lead to the development of more appropriate treatment strategies for gastric cancer.